To review records of patients treated with antipsychotics (including Adasuve, Geodon, Haldol) in order to evaluate outcomes.
A retrospective chart review will be performed for all patients presenting to the ED with agitation and subsequently given antipsychotic therapy for treatment. Identification of patients will be through chart review of patients presenting with agitation. Data to be recorded include patient age, gender, medical history, time of presentation, time of treatment, co morbidities, use of restraint, time to disposition and patient outcome. Inclusion criteria include all patients over age 18 presenting to the ED with agitation and treated with antipsychotics. No patients will be knowingly excluded from analysis. We will compare resulting outcomes of patients treated for agitation to see if Adasuve is superior to other commonly prescribed antipsychotics through its rate of discharge home and overall time in the emergency department.
Study Type
OBSERVATIONAL
Enrollment
93
Inhaled medication to treat acute agitation in the emergency department
Medication given to treat acute agitation in the emergency department
Length of stay in the emergency department
We will compare resulting outcomes of patients treated for agitation to see if Adasuve is superior to other commonly prescribed antipsychotics through its rate of discharge home and overall time in the emergency department.
Time frame: Participants will be followed for the duration of emergency department stay, an expected average of 12 hours.
Disposition
disposition (home, transfer, admit), and time to disposition
Time frame: Participants will be followed for the duration of emergency department stay, an expected average of 12 hours.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.